Question 1

How many clinical trials has First Affiliated Hospital of Zhejiang University sponsored?

Accepted Answer

ClinicalMetric currently tracks 12 clinical trials sponsored by First Affiliated Hospital of Zhejiang University, of which 12 are actively recruiting participants. These trials cover conditions including Acute Myeloid Leukemia (AML), CAR-T Cell Therapy, Consciousness Disorders. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

Question 2

What therapeutic areas does First Affiliated Hospital of Zhejiang University research focus on?

Accepted Answer

First Affiliated Hospital of Zhejiang University is a clinical research sponsor with 12 registered studies on ClinicalTrials.gov, of which 12 are actively recruiting participants. Research covers conditions including Acute Myeloid Leukemia (AML), CAR-T Cell Therapy, Consciousness Disorders, Aneurysms.

The trial portfolio spans Phase 1, Phase 3, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Question 3

How do I participate in a First Affiliated Hospital of Zhejiang University clinical trial?

Accepted Answer

To participate in a First Affiliated Hospital of Zhejiang University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all First Affiliated Hospital of Zhejiang University trials with current recruitment status updated daily.

First Affiliated Hospital of Zhejiang University

Frequently Asked Questions — First Affiliated Hospital of Zhejiang University

Clinical Trials by First Affiliated Hospital of Zhejiang University

A Study of A-CAR028 Treatment in Subjects With Relapsed or Refractory Acute Myeloid Leukemia

Micro-movements in Patients With Prolonged Disorders of Consciousness

Multicenter Study to Evaluate the Effectiveness and Safety of Flow-Diverting Stents for Distal Intracranial Aneurysms

Comparison of Etamsylate Versus Placebo to Prevent Bleeding in HSCT

Sequential Anti-Angiogenic Therapy After Immunotherapy in Advanced Biliary Tract Cancer

Anticoagulant Plus Antiplatelet Therapy Following Iliac Vein Stenting

Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer : a Randomized, Open-label, Parallel-controlled, Multi-center Phase III Study (NEOTORCH-BREAST04)

Radiotherapy Followed by Chemotherapy Combined With Toripalimab in Local Advanced HR-positive,HER2-negative BC.

The Efficacy and Safety of the Supraglottic Oxygenation Via Nasotracheal Intubation for Deep Sedation Fiberoptic Bronchoscopy

18F-Pentixafor PET in Hematologic Malignancies

Comparing the Efficacy of VHAG and Traditional Chemotherapy Regimens in Newly Diagnosed ETP-ALL

Blinatumomab Intensification for MRD-Negative Acute B-Cell Lymphoblastic Leukemia Before Allogeneic Hematopoietic Stem Cell Transplantation